Document Detail

Apoptosis in carcinoma of the bladder: relation with radiation treatment results.
MedLine Citation:
PMID:  10192349     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Radiotherapy is widely used in the treatment of bladder cancer. The search for biological parameters that could select patients who will respond to radiation treatment has become essential. The aim of this study is to assess whether the pretreatment apoptotic index is useful in predicting local control and survival in a group of bladder cancer patients treated by radiotherapy. METHODS AND MATERIALS: Fifty-five patients with invasive bladder carcinoma treated between 1983 and 1996 were included in this study. Radiotherapy was given to a median dose of 66 Gy, mean 63.28 Gy, in 1.8-2 Gy daily fractions. Apoptotic cells were studied in hematoxylin-eosin slides. Clinicopathological tumor characteristics were studied in relation to the apoptotic index, and as prognostic factors for local control and survival in both univariate and multivariate analysis. RESULTS: Pretreatment apoptotic indexes were related to tumor stage, mitotic index, and Ki67 proliferation index. Five-year actuarial local control for the whole group was 45%. Patients with tumors showing low pretreatment apoptotic indexes had better local control (p < 0.037) and survival (p < 0.01) than highly apoptotic tumors. Tumor stage (T2 vs. T3-4) and the pretreatment apoptotic index were significant predictive factors for local control and survival in multivariate analysis. CONCLUSIONS: The pretreatment apoptotic index is useful in predicting the clinical outcome of bladder cancer patients treated by radiotherapy. Assessment of biological tumor characteristics could allow the selection of patients for different treatment strategies.
P C Lara; S Pérez; A Rey; C Santana
Related Documents :
16336089 - Adjuvant chemotherapy for bladder cancer.
16773629 - Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in ...
6807679 - Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an eortc ...
15985089 - Sigmoidorectal (mainz ii) pouch for continent urinary diversion in bladder cancer.
25435719 - The efficacy of fludarabine, high dose cytosine arabinoside with granulocyte colony sti...
25377359 - Minimal residual disease as biomarker for optimal biologic dosing of ara-c in patients ...
15948539 - Cisplatin and weekly docetaxel as first-line therapy in patients with advanced non-smal...
12893339 - Positive prostate biopsy laterality and implications for staging.
6947779 - Epidermoid carcinoma compared with adenocarcinoma of the anal canal.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  43     ISSN:  0360-3016     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-04-13     Completed Date:  1999-04-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1015-9     Citation Subset:  IM    
Department of Radiation Oncology, Hospital Nuestra Señora del Pino, Las Palmas de Gran Canaria, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Carcinoma, Transitional Cell / mortality,  pathology,  radiotherapy*
Ki-67 Antigen / analysis
Reference Values
Regression Analysis
Urinary Bladder Neoplasms / mortality,  pathology,  radiotherapy*
Reg. No./Substance:
0/Ki-67 Antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective...
Next Document:  Rectal dosimetric analysis following prostate brachytherapy.